Breaking News Instant updates and real-time market news.

SPLK

Splunk

$101.07

-3.7 (-3.53%)

08:23
11/06/18
11/06
08:23
11/06/18
08:23

Splunk downgraded to Market Perform on decelerating growth at Bernstein

As previously reported, Bernstein analyst Mark Moerdler downgraded Splunk to Market Perform from Outperform as he believes growth is decelerating. The analyst has grown increasingly concerned that its strong reported revenue growth numbers in FY 2019 have been the result of increasing the duration on Term License contracts, which are now fully recognized up front under ASC 606, instead of ratably under ASC 605. Moerdler believes Splunk is likely still a potential acquisition target.

  • 15

    Nov

  • 29

    Nov

  • 05

    Dec

  • 06

    Dec

  • 10

    Dec

  • 09

    Jan

SPLK Splunk
$101.07

-3.7 (-3.53%)

11/06/18
BERN
11/06/18
DOWNGRADE
BERN
Market Perform
Splunk downgraded to Market Perform from Outperform at Bernstein
10/05/18
BMOC
10/05/18
NO CHANGE
Target $133
BMOC
Outperform
Splunk is showing 'good momentum', says BMO Capital
BMO Capital analyst Keith Bachman kept his Outperform rating and $133 price target on Splunk after attending its user conference, saying the double-digit growth in attendees to about 10K suggests that user interest in the platform remains high. The analyst also points to the positive feedback over Splunk's platform from its customers and partners and sees its offering as a "leader in data investigation and analytics". Bachman anticipates Splunk to continue expanding the use cases of its technology to drive increased customer demand.
10/04/18
KEYB
10/04/18
NO CHANGE
Target $132
KEYB
Overweight
Splunk price target raised to $132 from $120 at KeyBanc
KeyBanc analyst Liz Verity raised her price target for Splunk to $132 from $120, while reiterating an Overweight rating on the shares. Following the company's user conference and mid-quarter checks, the analyst has increased confidence in Splunk's ability to expand use cases, resulting in broader deployments of existing customers and attracting new ones.
08/28/18
ARGS
08/28/18
NO CHANGE
Target $135
ARGS
Buy
Splunk may become an acquisition target, says Argus
Argus analyst Joseph Bonner kept his Buy rating and $135 price target on Splunk but raised his FY19 EPS target to $1.12 from $1.05 after its Q2 earnings beat and FY19 guidance raise. Bonner contends that Splunk offers a "strong technology base" in a fast-growing market, though much of its success will depend on executing the ramp in software sales and market share capture without sacrificing margins. The analyst also believes that Splunk is "exactly the kind of company that could become an acquisition target for a larger enterprise software firm".

TODAY'S FREE FLY STORIES

WPC

W.P. Carey

$75.16

-0.02 (-0.03%)

07:36
02/19/19
02/19
07:36
02/19/19
07:36
Hot Stocks
W.P. Carey to invest $75M in food production facility in San Antonio »

W. P. Carey announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Feb

EBAY

eBay

$36.59

0.28 (0.77%)

07:36
02/19/19
02/19
07:36
02/19/19
07:36
Recommendations
eBay analyst commentary  »

eBay January trends…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    Mar

MIDD

Middleby

$126.19

2.13 (1.72%)

07:36
02/19/19
02/19
07:36
02/19/19
07:36
Hot Stocks
Middleby announces retirement of CEO Selim Bassoul »

The Middleby Corporation…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PEP

PepsiCo

07:36
02/19/19
02/19
07:36
02/19/19
07:36
Recommendations
PepsiCo analyst commentary  »

PepsiCo price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Feb

  • 18

    May

PATK

Patrick Industries

$47.06

2.01 (4.46%)

07:36
02/19/19
02/19
07:36
02/19/19
07:36
Recommendations
Patrick Industries analyst commentary  »

Patrick Industries price…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SB

Safe Bulkers

$1.60

-0.01 (-0.62%)

07:35
02/19/19
02/19
07:35
02/19/19
07:35
Earnings
Safe Bulkers reports Q4 adj. EPS 7c, consensus 8c »

Reports Q4 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Feb

NXRT

NexPoint Residential

$38.40

0.13 (0.34%)

07:35
02/19/19
02/19
07:35
02/19/19
07:35
Earnings
NexPoint Residential sees FY19 AFFO $2.16, consensus $2.24 »

Sees FY19 Same Store NOI…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Feb

DE

Deere

$158.99

-3.45 (-2.12%)

07:35
02/19/19
02/19
07:35
02/19/19
07:35
Recommendations
Deere analyst commentary  »

Too early to write off…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Feb

  • 27

    Feb

BHVN

Biohaven Pharmaceutical

$45.32

1.36 (3.09%)

07:34
02/19/19
02/19
07:34
02/19/19
07:34
Hot Stocks
Biohaven Pharmaceutical's verdiperstat receives FDA orphan drug designation »

Biohaven Pharmaceutical…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CGC

Canopy Growth

$47.54

1.49 (3.24%)

07:34
02/19/19
02/19
07:34
02/19/19
07:34
Downgrade
Canopy Growth rating change  »

Canopy Growth downgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Feb

NXRT

NexPoint Residential

$38.40

0.13 (0.34%)

07:33
02/19/19
02/19
07:33
02/19/19
07:33
Earnings
NexPoint Residential reports Q4 AFFO 47c, consensus 51c »

Reports Q4 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Feb

PRIM

Primoris

$21.29

0.09 (0.42%)

07:33
02/19/19
02/19
07:33
02/19/19
07:33
Hot Stocks
Primoris announces solar award valued over $170M »

Primoris announced a new…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Feb

NBL

Noble Energy

$22.63

0.62 (2.82%)

07:33
02/19/19
02/19
07:33
02/19/19
07:33
Hot Stocks
Noble Energy sees Q1 sales volumes 321-336 MBoe/d »

The Company anticipates…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Feb

NPO

EnPro

$72.21

2.81 (4.05%)

07:32
02/19/19
02/19
07:32
02/19/19
07:32
Downgrade
EnPro rating change  »

EnPro downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Feb

  • 13

    Mar

SAH

Sonic Automotive

$15.85

-0.03 (-0.19%)

07:31
02/19/19
02/19
07:31
02/19/19
07:31
Hot Stocks
Sonic Automotive raises quarterly dividend 67% to 10c per share »

Payable in cash for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Feb

CSL

Carlisle

$121.02

0.505 (0.42%)

07:31
02/19/19
02/19
07:31
02/19/19
07:31
Recommendations
Carlisle analyst commentary  »

Carlisle price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Mar

  • 08

    Mar

  • 13

    Mar

  • 14

    Mar

FCAU

Fiat Chrysler

$14.75

0.09 (0.61%)

07:30
02/19/19
02/19
07:30
02/19/19
07:30
Downgrade
Fiat Chrysler rating change  »

Fiat Chrysler downgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CHH

Choice Hotels

$80.53

-1.47 (-1.79%)

07:29
02/19/19
02/19
07:29
02/19/19
07:29
Recommendations
Choice Hotels analyst commentary  »

Choice Hotels reported…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

APTX

Aptinyx

$5.64

-0.07 (-1.23%)

07:29
02/19/19
02/19
07:29
02/19/19
07:29
Hot Stocks
Aptinyx doses first patient in Phase 2 NYX-783 study »

Aptinyx announced that it…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PLXP

PLx Pharma

$5.11

-0.11 (-2.11%)

07:27
02/19/19
02/19
07:27
02/19/19
07:27
Conference/Events
PLx Pharma to host special shareholder meeting »

Special shareholder…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Feb

NBRV

Nabriva Therapeutics

$2.08

0.045 (2.22%)

07:27
02/19/19
02/19
07:27
02/19/19
07:27
Hot Stocks
Nabriva Therapeutics announces FDA acceptance of lefamulin NDAs »

Nabriva Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    Apr

WORX

SCWorx

$5.74

-0.07 (-1.20%)

07:27
02/19/19
02/19
07:27
02/19/19
07:27
Hot Stocks
SCWorx announces new customer service agreement »

SCWorx has expanded its…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ARNC

Arconic

$17.56

0.07 (0.40%)

, JPM

JPMorgan

$105.56

3.14 (3.07%)

07:25
02/19/19
02/19
07:25
02/19/19
07:25
Hot Stocks
Arconic announces $700M accelerated share repurchase agreement »

Arconic (ARNC) announced…

ARNC

Arconic

$17.56

0.07 (0.40%)

JPM

JPMorgan

$105.56

3.14 (3.07%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Feb

ICPT

Intercept

$110.77

-0.42 (-0.38%)

07:24
02/19/19
02/19
07:24
02/19/19
07:24
Hot Stocks
Intercept intends to file for OCA regulatory approval in U.S., Europe in 2H19 »

"We are thrilled to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    May

CNMD

Conmed

$71.94

0.73 (1.03%)

07:24
02/19/19
02/19
07:24
02/19/19
07:24
Upgrade
Conmed rating change  »

Conmed reinstated with an…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Mar

  • 18

    May

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.